Last Updated on
The Food and Drug Administration (FDA) has approved a new medication to help treat adult type 2 diabetics. Every time a new drug hits the market, it’s important to understand the pros and cons of each treatment. Because there are always new drugs being developed for diabetes, we can always find better ways to manage glucose levels.
The new medication, Adlyxin which is developed by Sanofi is a glucagon like-reception (GLP-1) that is injected and will be used to treat type 2 coupled with diet and exercise. The GLP-1 is a hormone that is released after eating and will suppress glucagon secretion from cells in the pancreas and increase glucose-dependent insulin secretion.
Before they were awarded approval for the U.S., Sanofi conducted several clinical trials of the drugs to examine its effectiveness and safety. The medication has already been approved in over 60 countries. The drug was tested in 13 different trials that had over 5,000 type 2 adults across the world. In every test the medications met the standards set for diabetes treatments, but it did show a few mild side effects of vomiting, hypoglycemic episodes, and nausea.
Representatives from the FDA had a few comments on the new treatments for diabetics. Mary Thanh Hai Parks, M.D. who is a deputy director at the FDA’s Center for Drug Evaluation and Research expressed the departments thoughts on the drug, “The FDA continues to support the development of new drug therapies for diabetes management, Adlyxin will add to the available treatment options to control blood sugar levels for those with type 2.”
The new treatment will come in a disposable pen that is already filled with a single dose. Patients will get a disposable pen with a single treatment that they will take once a day for two weeks. After that, the dosage will increase to 20 micrograms every day.
Sanofi isn’t a newcomer to the diabetes drug arena. They are one of the world leaders in developing and marketing drugs to help maintain the condition and promote healthy glucose levels. As an organization, they have sites in our 40 different countries and are committed to researching new medications for a variety of diseases and conditions.
As a diabetic, it’s always exciting to hear of new medications and treatment options to hit the market. Having more options lets diabetics find the path that works best for them instead of everyone having the same treatment plan. Sure, every new medicine isn’t going to be a medical drug that completely changes the landscape of diabetes, but they more research that we put into treatments and the disease puts us one step closing to finding more permanent solutions.
If your treatments are not working as well as you would like, or you think a different medication could be more effective, as your doctor about a change of prescription. With all of the different medicines available, there could be a better combination that you haven’t tried yet. Your doctor should be able to make research decisions about which will work best for your specific situation.
As you already know, all of these treatments are designed to be used with a healthy diet and regular exercise. None of them is the silver bullet that is going to reverse your condition, but they are an excellent tool to help you get there.